Mechanisms underlying seizures and hypothermia during busulphan administration - Top-Institutions - MDSpire

Mechanisms underlying seizures and hypothermia during busulphan administration

  • By

  • Ibrahim El-Serafi

  • Sofia Berglund

  • Fadwa BenKessou

  • Alina Codita

  • Maryam Saghafian

  • David Lindskog

  • Matthijs C. Dorst

  • Gilad Silberberg

  • Manuchehr Abedi-Valugerdi

  • Wenyi Zheng

  • Rui He

  • Manon Renault

  • Weiying Zhou

  • Chao Yu

  • Massoud Vosough

  • Sandra Oerther

  • Ying Zhao

  • Jonas Mattsson

  • Moustapha Hassan

  • May 3, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Karolinska Institutet and Karolinska University Hospital
    Karolinska Institutet and Karolinska University Hospital

    Stockholm, Sweden

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Pharmacology

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, Washington

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Pharmacology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology/Oncology
    • Stem Cell Transplantation
    • Clinical Pharmacology

  • #4

    St. Jude Children’s Research Hospital
    St. Jude Children’s Research Hospital

    Memphis, Tennessee

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Stem Cell Transplantation
    • Pharmacology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, California

    Key Differentiators

    • Hematology/Oncology
    • Stem Cell Transplantation
    • Pharmacology

Original Source(s)

Mechanisms underlying seizures and hypothermia during busulphan administration

  • by Ibrahim El-Serafi, Sofia Berglund, Fadwa BenKessou, Alina Codita, Maryam Saghafian, David Lindskog, Matthijs C. Dorst, Gilad Silberberg, Manuchehr Abedi-Valugerdi, Wenyi Zheng, Rui He, Manon Renault, Weiying Zhou, Chao Yu, Massoud Vosough, Sandra Oerther, Ying Zhao, Jonas Mattsson, Moustapha Hassan

  • May 3, 2025

Related Content

This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet

Lilly moves to acquire Kelonia, plus gene therapy for deafness approved

  • April 27, 2026

  • 6 min
Correction to: Threshold of somatic mosaicism leading to brain dysfunction with focal epilepsy

  • February 11, 2025

This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

  • May 18, 2026

  • 7 min